Member Info for skid35

Squad.
They have already flagged growth and stated, not nearing, profitability (proper profitability not the ebitda type) in the update - but no real rerating but absolute audited confirmation may help.
Key on results is the forward view for the year, and what to do with the cash pile.
At current levels hopefully underwritten due to arr and good renewal rate, always the possibility of a juniper takeover.

Thanks chief, never really heard of them, looked at their website and realised why is never heard of them.
Back down to a level before the the year updates of profitability.

Herald held £125k worth at the end of 2020 when the price was higher so it really going to move the needle selling. As a £bn plus IT really insignificant / irrelevant holding to them as well.
Disappointing though as a sign of validation - as they hold £2m plus in calnex and £10m plus in spirent, plus a sprinkling of Israeli AIM companies and a chunk in napatech.

Weird price movement on zero public news. Hopefully nothing in the background on a cancelled renewal etc leaking out.

Fairview.
100% in agreement, my preference would be an investor meet and brokers note beforehand (hoping the second may happen as they are clearly not in London for this meeting) - with this meeting really just confirming what is therefore already in the public domain.

Just been reading the Herald it annual report, a good read for all those interested in tech in general but especially small/medium UK tech. They have sold their very small enet holding which was a ridiculously irrelevant % of their portfolio.
As they are well thought of in the market it would have been nice to see them holding or increasing. Looks like premier miton are the key UK institutional holder, hopefully the others are missing something we can see.

The most dangerous thing about 504/tl is his / her statements of fact from his contacts within the company, on the advfn board he stated 3/4 months ago the company had a $4m order for the du.
He thrives, for a period of time at least, due to a vacuum of background information and uncertainty from us investors in what constitutes rns info. Hopefully we have seen the first steps from the enet BOD here. I am sure a lot of tarana questions heading their way late April on revenue (initial/on going support), margin and working capital requirements.
Agree on you comments on profitability this year, key is seeing with more certainty into 23 what breakeven is and incremental % profit for each $ above this.
Hope your attending fairview?

Aspex.
No it doesnt. If you buy shares now you are not buying the associated warrants as a package, these are retained by the holder on the date a month or so ago.
You should be able to calculate your pbx holding, even though not tradable by opti holders you should be able to work out the holding value - these are worth c 11-12p per opti share held at the time.

Well said Dallo.
I also see it as a great sign of confidence by the BOD, and also the maturity (not necessarily in age but in investment understanding, it probably both) of the shareholder base in their communication with Mark seeing enet as a great medium / long term holding rather than a traders paradise.
Unless there is an RNS / brokers note beforehand I can still see, and fully understand, discussion of hard numbers for 2022 being slightly tempered - reiterating the existing communication.
What is more important is the product and operational strategy to take this to a $50m plus company in very short timescales, whilst having a clear timetable and actionable plan along the way. Already have a long list of questions here.
Looking forward to seeing everyone.

I'm with aj bell. Full communication on the distribution on when it will appear in the portfolio etc.
At the moment worth about 11-12p on top of you opti shareprice which you need to add in as a memo item at the moment until next year when they are issued.

This is a hell of an investment, but with all marketing these days it is very easy to look at ROI after the event. At current margin need to sell 1 m to "breakeven".
Key is that it is part of an overall campaign with supermarkets, Amazon etc.

Must say disagree with hagis on a sale, but it is important that the brand value of red leg is somehow reflected in the share price. Also I think our new shareholder and director is looking for a vehicle to build for the long term in the spirits market in the uk, the warrant exercise well above share price shows he is not concerned with the short term.

As others believe MR has distribution list of shareholders who have contacted him over the years.
A nice touch as this is one of the things I requested should they ever be over in London. Hopefully a good sign that both are over in London doing the rounds pressing the flesh as these things can easily be done by zoom.
Just rearranging diary to be there.

I know a number of you keep an eye on calnex as an early 5g market sign. Decent update this morning.
Just need clx IR to give ENET some tips.

Hi Bid, what is your twitter name ?

Bid, I don't have premium accounts as I don't really trade.

Outside the band here we don’t appear to have any new posters on either board for a few months who just happened to have stumbled upon ENET (as to be frank that is the way most of us have before further research).
We really do need some new holders prepared to take 100-200k shares and top up as the regular band do, would be nice to have another Irish whale joining in.
Whatever I think of the current share price and the company I am pretty much out of firepower and not prepared to sell other stock as I have in the past.
As most saw the report underwriting the current market cap with a lot to spare. Hopefully a gradual rise this year to give me the headache of warrant cash, please France no voting for ****** fruitcakes to upset the markets.

Mike.
I could write a long thread on each item here, full of factual inaccuracies and false assertions.
I know the "accountant" moniker is meant to be an insult. Like most qualified accountants haven't "done" accounting for 20 odd years - after working for US tech companies I now work in an organisation commercializing advanced science including spin outs and jvs - where KMK was 10 or so years ago.
For someone to say " a company cannot force customers to buy their products" shows a real lack of understanding of how business works at a really basic level.
Anyway, I hope the annual results provide a glimmer of hope, behind a really poor management team still lies a company with great potential.

Vascular.
It's about balance, I recognise the potential in kromek but they have a board full of lightweight academics unable of taking advantage of any commercial opportunity.
The problem is that any positive news of posts always promise opportunity in the future which actually never ever materialises, time and time again the company fails.
I post here to ensure balance, that potential new holders are aware of the dangers of putting their hard earned money behind a proven incompetent management team. With AROC it wasn't just incompetence, some real and deep ethics (and worse) issues here.

Aqc.
A lot of posters on this board kept on saying the aroc issues were in the past.
If, a very big IF, these can be recovered they provide a great source of funds. The problem is, yet again, if basu says these are recoverable he has so little / zero credibility no one believes him - with the exception of the naive buffoon Simon Thompson.

Dallo,
This is why I still buy when cash allows and hold, tarana on its own backs a much higher current share price and at the current price has very little downside (imho, dyor).
With a relatively low revenue required for breakeven this should hopefully throw off profit and cash in two / three years time - using a price earnings at a very conservative range of 20-30 provides for an incredible potential market cap and share price.